Skip to main content
Clinical Trials/NCT01760044
NCT01760044CompletedNot Applicable

Noninvasive Assessment of Tissue Perfusion Status in Critically Ill Pediatric Patients

University of Michigan1 site in 1 country46 target enrollmentStarted: January 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
46
Locations
1
Primary Endpoint
tissue oxygenation level as measured by raman spectroscopy device

Study Overview

Brief Summary

Investigators are conducting research about oxygen levels in the body and whether it is possible to use a device to measure oxygen in the body's tissues noninvasively, without blood draws or a catheter (a plastic tube placed in a vein). Investigators would like to know how this device compares to standard measurements using blood from a catheter. This may help treat patients who may not be getting enough oxygen to their body.

Detailed Description

Investigators will enroll patients in the pediatric intensive care unit who have an indwelling catheter that allows measurement of central venous oxygen saturation. Measurements of central venous oxygen saturation using blood oximetry will be compared with measures of tissue oxygenation at the buccal mucosa using a Raman spectroscopy tissue oximeter. Investigators will also measure the status of the sublingual microcirculation utilizing sidestream dark field microscopy. Basic demographic and clinical variables such as ongoing vasoactive infusions, mechanical ventilation, and laboratory data will also be collected.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Device Feasibility
Masking
None

Eligibility Criteria

Ages
30 Days to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients admitted to the Pediatric Intensive Care Unit (PICU) or Pediatric Cardiothoracic Unit (PCTU)
  • •Age >30 days and <18 years -patients with a "high" central venous line (ie internal jugular, subclavian, peripherally inserted central catheter, broviac, port) capable of blood draw and with central venous catheter tip in the superior vena cava

Exclusion Criteria

  • •Age <30 days or >18 years
  • •Known pregnancy or subsequently discovered pregnancy after admission
  • •Uncorrected cyanotic congenital heart disease
  • •Relative Exclusion Criteria:
  • •Oral trauma preventing placement of Raman StO2 oximeter probe or microcirculation video device
  • •Upper extremity trauma preventing placement of BEAM device

Arms & Interventions

Tissue oxygenation monitoring

Experimental

Tissue oxygenation monitoring

Intervention: Tissue oxygenation monitoring (Device)

Outcomes

Primary Outcomes

tissue oxygenation level as measured by raman spectroscopy device

Time Frame: The measures will occur twice within the first 24 hours of admission to the pediatric ICU and then whenever a central venous oxygen saturation is measured by the clinical care team until the patient is discharged from the pediatric ICU.

Measurement of tissue oxygenation level as based upon raman spectroscopy device will be compared with standard measures from central venous oxygen saturation from central venous catheters.

Secondary Outcomes

  • Microcirculation as recorded by sublingual video microcirculation recorder.(Twice in the first 24 hours after PICU admission)
  • Vital signs as recorded by Bioinformatically enabled armband monitor (BEAM)(Continuous from PICU admission through 24 hours of admission)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kevin Kuo

Fellow, Pediatric Critical Care

University of Michigan

Study Sites (1)

Loading locations...

Similar Trials